Biovacc-19: A Candidate Vaccine for Covid-19 (SARS-CoV-2) Developed from Analysis of its General Method of Action for Infectivity. (2nd June 2020)

Record Type:: Journal Article
Title:: Biovacc-19: A Candidate Vaccine for Covid-19 (SARS-CoV-2) Developed from Analysis of its General Method of Action for Infectivity. (2nd June 2020)
Main Title:: Biovacc-19: A Candidate Vaccine for Covid-19 (SARS-CoV-2) Developed from Analysis of its General Method of Action for Infectivity
Abstract:
Is Part Of:: QRB discovery. Volume 1(2020)
Journal:: QRB discovery
Issue:: Volume 1(2020)
Issue Display:: Volume 1, Issue 2020 (2020)
Year:: 2020
Volume:: 1
Issue:: 2020
Issue Sort Value:: 2020-0001-2020-0000
Page Start:
Page End:
Publication Date:: 2020-06-02
Subjects:: Biophysics -- Periodicals
571.4
Journal URLs:: https://www.cambridge.org/core/journals/qrb-discovery ↗
DOI:: 10.1017/qrd.2020.8 ↗
Languages:: English
ISSNs:: 2633-2892
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library HMNTS - ELD Digital store
Ingest File:: 21751.xml